Emergent BioSolutions Newsroom

Emergent BioSolutions Analyst Ratings

BenzingaDec 30, 2024 06:58 ET

HC Wainwright & Co. Initiates Coverage On Emergent BioSolutions With Buy Rating, Announces Price Target of $15

BenzingaDec 30, 2024 06:58 ET

H.C. Wainwright Initiates Emergent BioSolutions(EBS.US) With Buy Rating, Announces Target Price $15

Moomoo NewsDec 30, 2024 06:31 ET

Emergent BioSolutions Analyst Ratings

BenzingaNov 7, 2024 10:04 ET

Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsNov 7, 2024 08:31 ET

Emergent BioSolutions Analyst Ratings

BenzingaSep 13, 2024 11:48 ET

Emergent Biosolutions Price Target Announced at $16.00/Share by Rodman & Renshaw

Dow JonesAug 22, 2024 13:38 ET

Emergent BioSolutions Analyst Ratings

BenzingaAug 22, 2024 13:28 ET

Rodman & Renshaw Upgrades Emergent BioSolutions(EBS.US) to Buy Rating, Cuts Target Price to $16

Moomoo NewsAug 22, 2024 07:33 ET

Emergent BioSolutions Analyst Ratings

BenzingaAug 16, 2024 09:44 ET

Emergent BioSolutions Analyst Ratings

BenzingaAug 9, 2024 12:43 ET

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target

BenzingaAug 9, 2024 12:42 ET

Emergent BioSolutions Analyst Ratings

BenzingaJul 2, 2024 10:46 ET

Emergent BioSolutions Analyst Ratings

BenzingaJun 24, 2024 11:12 ET

Emergent BioSolutions Analyst Ratings

BenzingaJun 20, 2024 07:37 ET

Emergent BioSolutions Analyst Ratings

BenzingaApr 11, 2024 09:07 ET

Analysts' Top Healthcare Picks: Emergent Biosolutions (EBS), Vera Therapeutics (VERA)

TipRanksApr 11, 2024 07:25 ET

Emergent BioSolutions Analyst Ratings

BenzingaMar 7, 2024 10:41 ET

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Emergent Biosolutions (EBS)

TipRanksJan 11, 2024 10:20 ET

Emergent BioSolutions Analyst Ratings

BenzingaNov 20, 2023 08:27 ET